Fabrice Egros, Director at Syndax Pharmaceuticals Inc (SNDX), sold 25,535 shares at $18.65 ($476K) on 2021-05-18, disclosed to the SEC on 2021-05-20.
Open-market sale of $476k SNDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.65 | 1,683 | $31K | 6.6% |
| 2 | $18.65 | 11,926 | $222K | 46.7% |
| 3 | $18.65 | 11,926 | $222K | 46.7% |
| Total | $18.65 avg | 25,535 | $476K | 100% |
| Filing → |
| SNDX | SELL | 2021-03-03 | $496K | — | Filing → |